sub_topVisual

¼®¡¤¹Ú»ç Àü¹®°¡ ±¸Àμº±Õ°ü´ëÇб³ ´ëÇпø ¼®¡¤¹Ú»ç Àü¹®°¡ ±¸ÀÎ °Ô½ÃÆÇ ÀÔ´Ï´Ù.

Á¦¸ñ Ç÷§Æû¿¬±¸¼Ò ¿¬±¸¿ø ¸ðÁý Á¶È¸¼ö 186
ä¿ë±â°ü ¢ßÅøÁ¨ ÇÐÀ§±¸ºÐ ¼®¡¤¹Ú»ç
ºÐ¾ß °³¹ß ¸ðÁý±â°£(¸¶°¨ÀÏ) ä¿ë½Ã
÷ºÎÆÄÀÏ µî·ÏÀÏ 2019.03.11

1. ¸ðÁýºÐ¾ß ¹× ÀÚ°Ý¿ä°Ç

¸ðÁýºÐ¾ß

´ã´ç¾÷¹«

ÀÚ°Ý¿ä°Ç

¸ðÁýÀοø

Ç÷§Æû ¿¬±¸¼Ò

À¯ÀüÀÚ °¡À§ Ç÷§Æû °³¹ß

A) CRISPR-Cas9 ÃÖÀûÈ­

B) CRISPR¸¦ ÀÌ¿ëÇÑ Target discovery

ÇзÂ: ´ëÇпø(¼®»ç)ÀÌ»ó

Cloning, Cell line cultureµî ±âº»ÀûÀÎ molecular biology¿¡ ´ÉÅëÇÑ ÀÚ

 

[¿ì´ëÁ¶°Ç]

A) Protein engineering °æÇèÀÚ ¿ì´ë

B) High-throughput Screening (ºÐ¾ß »ó°ü¾øÀ½) °æÇèÀÚ ¿ì´ë

¹Ú»ç±Þ O¸í

 

¼®»ç±Þ O¸í

 

2. ±Ù¹«Á¶°Ç

±Ù¹«ÇüÅÂ: Á¤±ÔÁ÷

±Ù¹«Áö: ¼­¿ï > ±Ýõ±¸

±Ù¹«¿äÀÏ: ÁÖ5ÀÏ

±Ù¹«½Ã°£: 08½Ã 30ºÐ ~ 17½Ã 30ºÐ

±Þ¿©: ȸ»ç³»±Ô¿¡ µû¸§(¸éÁ¢ ÈÄ °áÁ¤)

 

3. ÀüÇüÀÏÁ¤

¼­·ùÀüÇü > 1Â÷¸éÁ¢ > 2Â÷(ÀÓ¿ø)¸éÁ¢ > ÃÖÁ¾ÇÕ°Ý

¡Ø¸éÁ¢ÀÏÁ¤Àº ÃßÈÄ Å뺸µË´Ï´Ù.

 

4. Á¢¼ö¹æ¹ý

Á¢¼ö±â°£: 2019.05.07.(È­)±îÁö (ä¿ë½Ã¸¶°¨)

Á¢¼ö¹æ¹ý: ÀâÄÚ¸®¾Æ Á¢¼ö(http://www.jobkorea.co.kr/Recruit/GI_Read/27870370?rPageCode=GL)

À̷¼­: ÀâÄÚ¸®¾ÆÀ̷¼­, ÀÚÀ¯À̷¼­

 

5. ±âŸ»çÇ×

ÇãÀ§»ç½ÇÀÌ ¹ß°ßµÉ °æ¿ì ä¿ëÀÌ Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.

³í¹® ¹× ƯÇã ½ÇÀû ¸ñ·Ï / ÇÐÀ§ ¹× ¼ºÀûÁõ¸í¼­

 

top